ArticleFrontiers in neurology2021

A Novel Immune Classification for Predicting Immunotherapy Responsiveness in Patients With Adamantinomatous Craniopharyngioma.

Feng Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.